BrightFocus Foundation is at the forefront of brain and eye health, advancing early-stage, investigator-initiated research around the world. Our programs are designed to provide initial funding for highly innovative experimental ideas for Alzheimer's disease, macular degeneration, and glaucoma.
Most of the awardees use their donor award money to demonstrate key findings that lead to later interest and additional funding from industrial or governmental funding agencies. It’s our firm belief that having the courage to invest in innovative ideas will lead to revolutionary treatments, preventions, and cures.
Our programs are supported entirely by private contributions from the general public and by corporate and foundation grants. The foundation receives no government grants.
Programs and History
Alzheimer's Disease Research Program
The Alzheimer's Disease Research (ADR) program began in 1985 and since its inception has awarded more than $100.5 million to support promising research in fields ranging from molecular biology to genetics to epidemiology. ADR is currently supporting 85 outstanding biomedical research projects after awarding 32 new grants.
Macular Degeneration Research Program
Since 1999, the Macular Degeneration Research (MDR) program has awarded more than $21.5 million to support research into the causes and potential preventions and treatments of macular degeneration disease. MDR is currently supporting 40 biomedical research projects after awarding 20 new grants.
National Glaucoma Research Program
Since the National Glaucoma Research (NGR) program began in 1978, BrightFocus has awarded more than $28.6 million to support research projects on the causes and potential prevention and treatment of this disease. NGR is currently supporting 31 biomedical research projects, after recently awarding 13 new grants.